1 / 33

CANCER: ECONOMIC CONSEQUENCES FOR SA

Evaluating the socio-economic benefits of innovation. CANCER: ECONOMIC CONSEQUENCES FOR SA. Tienie Stander Campaigning for Cancer Conference 6 October 2007. ACKNOWLEDGEMENTS. Sponsors: Roche Products Wynand Harmse (B Eng (E&E), M Sc Eng)

cooper-wilkerson
Download Presentation

CANCER: ECONOMIC CONSEQUENCES FOR SA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Evaluating the socio-economic benefits of innovation CANCER:ECONOMIC CONSEQUENCES FOR SA Tienie Stander Campaigning for Cancer Conference 6 October 2007

  2. ACKNOWLEDGEMENTS • Sponsors: Roche Products • Wynand Harmse (B Eng (E&E), M Sc Eng) • Rhonda Shaw (B Com (Econometrics), B Com (Hons – Actuarial Mathematics) • National Cancer Registry: N Mqoqi • MRC: Prof. D Bradshaw, Dr. R Norman • UCT: Dr. D Bourne • Stats SA

  3. 1. THE PROBLEM • Burden of Cancer trends in SA • Cancer as % of all cause death (2004): 5.65%

  4. CANCER MORTALITY: FEMALE

  5. CANCER MORTALITY: MALE

  6. CANCER INCIDENCE

  7. INCIDENCE: ASIAN FEMALE

  8. INCIDENCE: BLACK FEMALE

  9. INCIDENCE: COLOURED FEMALE

  10. INCIDENCE: WHITE FEMALE

  11. INCIDENCE: ASIAN MALE

  12. INCIDENCE: BLACK MALE

  13. INCIDENCE: COLOURED MALE

  14. INCIDENCE: WHITE MALE

  15. BURDEN OF DISEASE • MRC results 2000: 520,883 Bradshaw D., Groenewald P., Laubscher R., Nannan N., Nojilana B., Norman R., Pieterse D., Schneider M. Initial Burden of Disease Estimates for South Africa, 2000. Medical Research Council, Burden of Disease Research Unit. March 2003. • MRC results 2000 revised: 501,044 Email discussions with Rosana Norman, Burden of Disease Research Unit of the South African Medical Research Council. • heXor results 2000: 494,292

  16. CANCER: BOD

  17. BURDEN OF DISEASE

  18. 2. ROLE OF DOH • Constitution of SA • Assuring access to healthcare • Why invest in health?

  19. 3. CONSEQUENCES Emotional Physical Financial Economic Global

  20. 3.1 DIRECT COSTS • Private sector • Public sector

  21. PRIVATE SECTOR Cancer consumes 4% of private healthcare funds (R2,112 million)

  22. PRIVATE SECTOR Medicine: R430 mil., Practitioners: R1,200 mil., Hospitals R402 mil.

  23. PUBLIC SECTOR Cancer consumes 2.9% of public healthcare funds (R1,693 million)

  24. PUBLIC SECTOR Regional governments spend 84% of cancer budget (R1,428 mil.)

  25. 3.2 INDIRECT COST • Definition: loss of economic productivity due to both premture mortality and morbidity • Human Capital Method: present value of an individuals future earnings • Data: mortality, income and survival

  26. RESULTS

  27. RESULTS: SA

  28. Healthy Life 100% YLD YLL 0% ∆ † E† DISCUSSION

  29. Healthy Life 100% YLD YLL 0% ∆ † E† DISCUSSION

  30. Healthy Life 100% 0% E† DISCUSSION

  31. SUMMARY • Cancer survivors are increasing • Economic costs substantial • Indirect costs are neglected

  32. THANK YOU

More Related